January 27, 2026 a 08:38 am
AFL: Analysts Ratings - Aflac Incorporated
Aflac Incorporated, a prominent provider of supplemental health and life insurance, showcases resilience in its diverse market operations in Japan and the U.S. Analyst ratings over recent months hint at cautious optimism, balanced by a significant number of 'Hold' ratings. This suggests hesitation among analysts about substantial upside potential despite the stable business model and international presence.
Historical Stock Grades
| Recommendation | Count | Score Bar |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 1 | |
| Hold | 7 | |
| Sell | 2 | |
| Strong Sell | 1 |
Sentiment Development
- Over the last year, the number of total analyst ratings shifted slightly, with a continued emphasis on 'Hold' positions.
- With minimal changes in 'Strong Buy' and 'Buy' categories, the sentiment reflects a cautious approach to Aflac's growth potential.
- 'Hold' ratings remain predominant, suggesting a market consensus on stable, albeit unspectacular, performance.
Percentage Trends
The analyst consensus for Aflac Incorporated has experienced slight shifts over recent months, indicating nuanced sentiment changes:
- Strong Buy ratings have remained low, emphasizing conservative estimates regarding outperforming market expectations.
- Hold ratings have maintained the largest share, reflecting general sentiment of stability without significant growth projections.
- The absence of significant increases in Buy ratings indicates restrained optimism without aggressive confidence in upward movements.
- Changes across the board suggest analysts are taking a wait-and-see approach, reflecting prudent analyses amidst uncertain macroeconomic influences.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-08 | Underweight | Underweight | Barclays |
| 2026-01-05 | Neutral | Neutral | JP Morgan |
| 2025-12-30 | Outperform | Outperform | Raymond James |
| 2025-12-22 | Hold | Hold | TD Cowen |
| 2025-11-17 | Equal Weight | Equal Weight | Morgan Stanley |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2024-01-04 | Underperform | In Line | Evercore ISI Group |
| 2023-08-18 | Equal Weight | Overweight | Morgan Stanley |
| 2023-08-17 | Equal Weight | Overweight | Morgan Stanley |
| 2021-01-12 | Overweight | Equal Weight | Morgan Stanley |
| 2021-01-11 | Overweight | Equal Weight | Morgan Stanley |
Interpretation
The collective analyst sentiment towards Aflac Incorporated signals a market that perceives the stock as stable, albeit lacking aggressive growth triggers. Despite operational strength in Japan and the U.S., the predominant 'Hold' consensus suggests a degree of caution influenced by external economic conditions. The stability in ratings, particularly the 'Hold' dominance, may underscore a balanced view of current valuation against potential volatility. However, occasional downgrades reflect localized concerns about market dynamics or competitive pressures.
Conclusion
Aflac Incorporated's current analyst consensus, characterized predominantly by 'Hold' ratings, reflects cautious sentiment amid stable operational performance. With a lack of widespread upgrades or downgrades, market analysts appear to prioritize stability and predictability. While the company maintains robust market positions in key regions, the sentiment highlights existing macroeconomic uncertainties that could be influencing a conservative approach to future predictions. Considering Aflac's strengths and potential vulnerabilities, investors are advised to weigh these insights against broader market trends before making strategic decisions.